Emerging therapies for cerebrovascular disorders

Stroke. 2004 Feb;35(2):367-9. doi: 10.1161/01.STR.0000115296.67346.28.
No abstract available

Publication types

  • Editorial
  • Review

MeSH terms

  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Atorvastatin
  • Cerebrovascular Circulation / drug effects
  • Cerebrovascular Disorders / drug therapy*
  • Cerebrovascular Disorders / prevention & control
  • Heptanoic Acids / therapeutic use
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Hypertension / drug therapy
  • Intracranial Aneurysm / surgery
  • Intracranial Aneurysm / therapy
  • Pyrroles / therapeutic use
  • Randomized Controlled Trials as Topic / statistics & numerical data
  • Risk
  • Simvastatin / therapeutic use
  • Therapeutics / trends*
  • Tissue Plasminogen Activator / therapeutic use
  • Treatment Outcome

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Heptanoic Acids
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Pyrroles
  • Atorvastatin
  • Simvastatin
  • Tissue Plasminogen Activator